Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Minotti

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
JACC. Cardiooncology|August 16, 2021
Acute Heart Failure 29 Years After Treatment for Childhood CancerMassimiliano Camilli, Marco Giuseppe Del Buono, Filippo Crea, et al.
Progress in Cardiovascular Diseases|July 18, 2024
Anthracyclines, Diastolic Dysfunction and the road to Heart Failure in Cancer survivors: An untold storyMassimiliano Camilli, Péter Ferdinandy, Emanuela Salvatorelli, et al.
Chemotherapy|August 24, 2020
Further Analytical, Pharmacokinetic, and Clinical Observations on Low-Dose Ponatinib in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaPierantonio Menna, Ugo De Grazia, Francesco Marchesi, et al.
Methods in Enzymology|March 25, 2004
Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanismsGiorgio Minotti, Stefania Recalcati, Pierantonio Menna, et al.
British Journal of Haematology|August 2, 2019
Efficacy and safety of low dose ponatinib in a case of Ph-positive acute lymphoblastic leukaemiaFrancesco Marchesi, Emanuela Salvatorelli, Daniela Renzi, et al.
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
AnthracyclinesLuca Gianni, Giacomo Grasselli, Sara Cresta, et al.
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
AnthracyclinesLuca Gianni, Giacomo Grasselli, Sara Cresta, et al.
Chemotherapy|January 16, 2018
Modified Colistin Regimen for Critically Ill Patients with Acute Renal Impairment and Continuous Renal Replacement TherapyPierantonio Menna, Emanuela Salvatorelli, Alessia Mattei, et al.
Autoimmunity Reviews|May 5, 2011
Cardiovascular safety of anti-TNF-alpha therapies: facts and unsettled issuesFabio Cacciapaglia, Luca Navarini, Pierantonio Menna, et al.
Expert Opinion on Drug Safety|August 9, 2003
Cardiotoxic effects of anthracycline-taxane combinationsAntonella Perotti, Sara Cresta, Giacomo Grasselli, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
JACC. Cardiooncology|August 16, 2021
Acute Heart Failure 29 Years After Treatment for Childhood CancerMassimiliano Camilli, Marco Giuseppe Del Buono, Filippo Crea, et al.
Progress in Cardiovascular Diseases|July 18, 2024
Anthracyclines, Diastolic Dysfunction and the road to Heart Failure in Cancer survivors: An untold storyMassimiliano Camilli, Péter Ferdinandy, Emanuela Salvatorelli, et al.
Chemotherapy|August 24, 2020
Further Analytical, Pharmacokinetic, and Clinical Observations on Low-Dose Ponatinib in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaPierantonio Menna, Ugo De Grazia, Francesco Marchesi, et al.
Methods in Enzymology|March 25, 2004
Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanismsGiorgio Minotti, Stefania Recalcati, Pierantonio Menna, et al.
British Journal of Haematology|August 2, 2019
Efficacy and safety of low dose ponatinib in a case of Ph-positive acute lymphoblastic leukaemiaFrancesco Marchesi, Emanuela Salvatorelli, Daniela Renzi, et al.
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
AnthracyclinesLuca Gianni, Giacomo Grasselli, Sara Cresta, et al.
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
AnthracyclinesLuca Gianni, Giacomo Grasselli, Sara Cresta, et al.
Chemotherapy|January 16, 2018
Modified Colistin Regimen for Critically Ill Patients with Acute Renal Impairment and Continuous Renal Replacement TherapyPierantonio Menna, Emanuela Salvatorelli, Alessia Mattei, et al.
Autoimmunity Reviews|May 5, 2011
Cardiovascular safety of anti-TNF-alpha therapies: facts and unsettled issuesFabio Cacciapaglia, Luca Navarini, Pierantonio Menna, et al.
Expert Opinion on Drug Safety|August 9, 2003
Cardiotoxic effects of anthracycline-taxane combinationsAntonella Perotti, Sara Cresta, Giacomo Grasselli, et al.
Pageof 13